BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/28/2021 10:00:16 AM | Browse: 547 | Download: 1026
 |
Received |
|
2021-02-18 03:25 |
|
Peer-Review Started |
|
2021-02-18 03:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-07 22:05 |
|
Revised |
|
2021-04-07 22:35 |
|
Second Decision |
|
2021-08-30 03:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-30 06:57 |
|
Articles in Press |
|
2021-08-30 06:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-23 05:36 |
|
Publish the Manuscript Online |
|
2021-09-28 10:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Clinical considerations for critically ill COVID-19 cancer patients: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chidambaram Ramasamy, Ajay Kumar Mishra, Kevin John John and Amos Lal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amos Lal, FACP, MBBS, Doctor, Doctor, Department of Medicine, Division of Pulmonary and Critical Care medicine , Mayo Clinic, 200 First st, SW, Rochester, MN 55902, United States. lal.amos@mayo.edu |
| Key Words |
COVID-19; Cancer; Critical care; Mortality; Pandemic |
| Core Tip |
Based on the analyses of 18 studies from major national and international cancer registries, it is evident that among symptomatic coronavirus disease 2019 (COVID-19) cancer patients, approximately one in six patients required intensive level of care, and one in four patients had a fatal outcome. It is crucial to identify factors associated with the worse outcome as it helps to provide prognostic enrichment while discussing the goals of care in this specific patient population. Appropriate contingency planning for these patients in terms of goals of care and judicious resource allocation in the resource-poor regions is the key. Later studies showed an absence of association between mortality from COVID-19 infection and active cytotoxic or noncytotoxic chemotherapy and it could be continued with caution. |
| Publish Date |
2021-09-28 10:00 |
| Citation |
Ramasamy C, Mishra AK, John KJ, Lal A. Clinical considerations for critically ill COVID-19 cancer patients: A systematic review. World J Clin Cases 2021; 9(28): 8441-8452 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i28/8441.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i28.8441 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
